Get the Stockscreener App
101.95
1.51%
-1.56
After Hours:
101.30
-0.65
-0.64%
Genedx Holdings Corp stock is traded at $101.95, with a volume of 1.18M.
It is down -1.51% in the last 24 hours and up +10.44% over the past month.
GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. The company is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets.
See More
Previous Close:
$103.51
Open:
$101.058
24h Volume:
1.18M
Relative Volume:
0.99
Market Cap:
$2.91B
Revenue:
$267.23M
Net Income/Loss:
$-83.50M
P/E Ratio:
-32.78
EPS:
-3.11
Net Cash Flow:
$-59.99M
1W Performance:
+25.17%
1M Performance:
+10.44%
6M Performance:
+36.21%
1Y Performance:
+211.58%
1-Day Range:
$98.50
$103.91
1-Week Range:
$78.99
$107.31
52-Week Range:
$25.32
$117.75
Genedx Holdings Corp Stock (WGS) Company Profile
Name
Genedx Holdings Corp
Sector
Industry
Phone
888-729-1206
Address
333 LUDLOW STREET, STAMFORD
Compare WGS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
WGS
Genedx Holdings Corp
|
101.95 | 2.97B | 267.23M | -83.50M | -59.99M | -3.11 |
|
TMO
Thermo Fisher Scientific Inc
|
467.68 | 180.17B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
197.16 | 146.07B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
534.31 | 46.01B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
114.81 | 33.53B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
185.86 | 32.56B | 15.50B | 1.33B | 2.16B | 7.34 |
Genedx Holdings Corp Stock (WGS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-09-25 | Initiated | Piper Sandler | Overweight |
| May-15-25 | Initiated | Guggenheim | Buy |
| May-09-25 | Upgrade | Jefferies | Hold → Buy |
| Aug-28-24 | Initiated | Wells Fargo | Equal Weight |
| Jul-10-24 | Initiated | Craig Hallum | Buy |
| Jun-03-24 | Resumed | Jefferies | Hold |
View All
Genedx Holdings Corp Stock (WGS) Latest News
GeneDx Holdings Corp. Executives Sell Shares for Tax Obligations - TradingView
GeneDx Surges Past Q2 Expectations, Sets Up For Strong Year-End Growth (NASDAQ:WGS) - Seeking Alpha
GeneDx Holdings Corp. (NASDAQ:WGS) Q2 2025 Earnings Call Transcript - Insider Monkey
What makes GeneDx Holdings Corp. Equity Warrant stock price move sharplyChart Pattern Guidance To Watch Now - jammulinksnews.com
GeneDx investigated for securities law violations, allegedly fraudulent practices. - AInvest
WGS Investors Have Opportunity to Join GeneDx Holdings Corp. Investigation With the DJS Law Group - PR Newswire
What makes GeneDx Holdings Corp. stock price move sharplyDaily Chart Pattern Stock Forecast Shows Bullish Setup - beatles.ru
GeneDx Reports Record Revenue and Growth in Q2 2025 - TipRanks
Why GeneDx Holdings Stock Crushed It Again Today - Nasdaq
Bullish Candlestick Pattern Forms in GeneDx Holdings Corp.Low Drawdown Real Time Trading Tips Shared - beatles.ru
GeneDx Holdings Corp. Investors: Company Investigated by the Portnoy Law Firm - GlobeNewswire
GeneDx raises 2025 revenue guidance to $415M and exome/genome revenue growth to 52% while accelerating NICU and pediatric market expansion - MSN
GeneDx Holdings Stock Keeps Rising. Is It Too Much? - StocksToTrade
GeneDx Holdings (WGS) Is Up 13.4% After Strong Q2 Profit and Raised 2025 Revenue Outlook - simplywall.st
GeneDx Holdings Second Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
GeneDx stock price target raised to $125 from $100 at BTIG on strong Q2 - Investing.com Nigeria
What’s the recovery path for long term holders of GeneDx Holdings Corp.Pattern Breakout Entry Stock Forecast in Focus - metal.it
Applying sector rotation models to GeneDx Holdings Corp. Equity WarrantFundamental Analysis for Value Stock Selection - Newser
Will GeneDx Holdings Corp. Equity Warrant rebound enough to break evenFree Fundamental + Technical Hybrid Stock Tips - Newser
Institutional scanner results for GeneDx Holdings Corp. Equity WarrantROI Focused Watchlist with Trade Confidence - Newser
GeneDx Holdings Corp (WGS) Q2 2025 Earnings Call Highlights: Record Revenue and Strategic ... By GuruFocus - Investing.com Canada
Why GeneDx Holdings Corp. Equity Warrant stock attracts strong analyst attentionInvestment Roadmap for High Potential Stocks - Newser
GeneDx Holdings Reports Strong Q2 2025 Results - TipRanks
GeneDx Holdings Corp. Equity Warrant Stock Fails to Break Resistance Traders ReactNews Based Entry Opportunity Alerts Detected - metal.it
GENEDX (WGS) ALERT: Bragar Eagel & Squire, P.C. is - GlobeNewswire
GENEDX (WGS) ALERT: Bragar Eagel & Squire, P.C. is Investigating GeneDx Holdings Corp. on Behalf of GeneDx Stockholders and Encourages Investors to Contact the Firm - GlobeNewswire Inc.
Why GeneDx Holdings Stock Blasted 8% Higher Today - Nasdaq
Quant Models Detect Momentum Reversal in GeneDx Holdings Corp. Equity WarrantTrade Timing Strategy With Technical Data Explained - metal.it
GeneDx Q2 2025 Earnings Call Transcript - MarketBeat
How Resilient Is GeneDx Holdings Corp. Stock During Economic DownturnsAutomated AI Forecast with Trading Alerts - Newser
GeneDx Holdings Corp. Equity Warrant stock retracement – recovery analysisNeural Network Based Equity Prediction System - Newser
GeneDx Holdings Corp. 2025 Q2ResultsEarnings Call Presentation (NASDAQ:WGS) - Seeking Alpha
How Resilient Is GeneDx Holdings Corp. Equity Warrant Stock During Economic DownturnsMarket Correction Proof Stock Screening Analysis - Newser
WGS Investor News: If You Have Suffered Losses in GeneDx Holdings Corp. (NASDAQ: WGS), You Are ... - Bluefield Daily Telegraph
GeneDx - Hartford Business Journal
Is GeneDx Holdings Corp. Starting a New UptrendWeekly Return Pick Forecast Reports Show Trend - metal.it
Stamford-based GeneDx tops $100M in revenue in Q2, posts 4th straight profitable quarter - Hartford Business Journal
Earnings call transcript: GeneDx Q2 2025 beats forecasts, stock surges - Investing.com
Momentum Screeners Rank GeneDx Holdings Corp. in Top 5 TodayFast Return Equity Trade Forecast Points to Small Caps - metal.it
WGS Stock Gains on Q2 Earnings and Revenue Beat, Raises '25 Sales View - Yahoo Finance
GeneDx Holdings Corp reports results for the quarter ended June 30Earnings Summary - TradingView
GeneDx Holdings Corp. SEC 10-Q Report - TradingView
GeneDx Lifts Guidance After Genetic Test Demand Drives Strong Quarter - Finimize
GeneDx Holdings Stocks Surge Amid Strong Q2 Results - TipRanks
GeneDx Holdings Corp. (WGS) Q2 Earnings and Revenues Beat Estimates - 富途牛牛
GeneDx's Q2 2025 Earnings and Strategic Momentum in Genomic Diagnostics - AInvest
GeneDx Reports Second Quarter 2025 Financial Results and Business Highlights - TradingView
BMNR authorizes $1B share buyback, signs Cantor Fitzgerald deal | WGS SEC FilingForm 8-K - Stock Titan
Key metrics from GeneDx Holdings Corp.’s quarterly dataRisk-Managed Strategy Based on Price Analysis - Newser
GeneDx Q2 2025 slides: Revenue surges 49%, company raises full-year guidance - Investing.com Nigeria
GeneDx shares soar 25% as exome and genome testing revenue surges 69% - Investing.com Australia
Genedx Holdings Corp Stock (WGS) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.45%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):